BEIJING, February 17, 2015 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2014 financial results on, March 4, 2015, after the market closes.
The Company’s management will hold a conference call at 7:30a.m. ET on Thursday, March 5, 2015, which is 8:30p.m., Beijing Time on, March 5, 2015, to discuss fourth quarter and fiscal year 2014 results. Listeners may access the call by dialing:
1 888 346 8982
1 412 902 4272
800 905 945
400 120 6113
A telephone replay will be available one hour after the conclusion of the conference call through March 12, 2015. The dial-in details are:
1 877 344 7529
1 412 317 0088
A live and archived webcast of the conference call will be available through the Company’s investor relations website at http://chinabiologic.investorroom.com.
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 different dosages of plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi’an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company’s website www.chinabiologic.com.
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-biologic-products-to-report-fourth-quarter-and-fiscal-year-2014-financial-results-300036311.html